NEOS THERAPEUTICS INC - COM (NEOS)

CUSIP: 64052L106

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
6,225,796
Share change
+30,816
Total reported value
$67,166,216
Price per share
$10.79
Number of holders
45
Value change
-$1,162,281
Number of buys
24
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) as of Q1 2016

As of 31 Mar 2016, NEOS THERAPEUTICS INC - COM (NEOS) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,225,796 shares. The largest 10 holders included Sio Capital Management, LLC, FRANKLIN RESOURCES INC, DSC Advisors, L.P., DEERFIELD MANAGEMENT CO, EMERALD MUTUAL FUND ADVISERS TRUST, BlackRock Fund Advisors, EMERALD ADVISERS INC/PA, VANGUARD GROUP INC, PUTNAM INVESTMENTS LLC, and Hodges Capital Management Inc.. This page lists 45 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.